Bear Mountain Capital, Inc.

Position in DNLI — Denali Therapeutics Inc.

CIK 2009419 SEATTLE, WA

Position in DNLI

as of Jun 30, 2026 · filed Jul 20, 2026 Compact

Position Value

$565

New position

Shares Held

22

first reported quarter

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#268

of 286 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Bear Mountain Capital, Inc. holds $5,936 across 5 Biotechnology names. DNLI ranks #2 (9.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	OMER	Omeros Corp	485	$4,612
2	DNLI	Denali Therapeutics Inc. This page	22	$565
3	IMNM	Immunome Inc.	20	$423
4	CRSP	CRISPR Therapeutics AG	6	$327
5	NVAX	Novavax Inc	1	$9

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$565	22	—	Shares	Sole	2026-07-20
No filing history on record for this holder in this stock.